ISSCR News
ISSCR Applauds Reversal of U.S. Policies Restricting Fetal Tissue Research
The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, applauds HHS Secretary Xavier Becerra for lifting the restrictions on research using fetal tissue. ISSCR President Christine Mummery released the following statement..
The ISSCR Will Release Updated Guidelines for Stem Cell Research and Clinical Translation in May
Skokie, IL - The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, announced that the society’s updated Guidelines for Stem Cell Research and Clinical Translation will be released in May 2021.
The ISSCR Joins Coalition Letter Supporting NIH Funding
The ISSCR joined 360 members of the Ad Hoc Group for Medical Research to share recommendations for National Institutes of Health (NIH) funding for 2022. The letter stresses the need for reliable annual funding support for the NIH a key national priority. The Ad Hoc Group for Medical Research represents patient groups, scientific societies, research and academic institutions, health professionals, educators, and industry,
The ISSCR Urges HHS to Rescind the Proposed Rule on Human Fetal Tissue Research
94 Scientific, Medical, and Patient Organizations Sign-on to Comment LetterThe ISSCR has submitted comments urging the Department of Health and Human Services (HHS) to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). Among other key points, the letter states that the proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19.
The ISSCR Comments on EMA Draft Guidance on Registry-based Studies
The ISSCR recently delivered comments on the draft Guideline on Registry-based Studies (EMA/502388/2020). Among other points, the letter stated support the crucial role of the European Medicines Agency (EMA) in overseeing the development of safe and effective new products and the draft Guideline on Registry-based Studies. The Society also encouraged EMA to clarify the appropriate uses for patient registries to prevent them from being abused by businesses seeking to prematurely commercialize unproven stem cell-based interventions.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .